Currently, JPIAMR is a collaboration between 28 member countries. The JPIAMR is a partnership in which Member States work together on the theme of antimicrobial resistance, with support of the European Commission. The initiative coordinates national funding to support transnational research and activities within the six priority areas of the shared JPIAMR Strategic Research and Innovation Agenda (SRIA, update published 2019) – therapeutics, diagnostics, surveillance, transmission, environment and interventions. Additionally, the JPIAMR is currently developing a platform to extend shared research capabilities on a global scale through the Virtual Research Institute (JPIAMR-VRI). The mission for the period 2020-2025 is to join forces of the participating nations by initiating the alignment, coordination and support of global antimicrobial resistance One Health research and policy activities.
The JPIAMR Strategic Research & Innovation Agenda (SRIA) presents an overview of recent developments and future needs for AMR research.
The SRIA recognises that antimicrobials include antibiotics, antifungals, antivirals and antiparasitics.
The current focus of the SRIA is antibiotic resistance. Recently, JPIAMR members have decided to conduct an expert consultation to identify antifungal research priorities in order to broaden the current SRIA. The objective of the process and this survey is to develop specific research objectives for both antibiotic and antifungal research to be combined in the different priority areas of the SRIA.
A public consultation for the inclusion of antifungals in the JPIAMR SRIA is now opened. For more information and a link to the survey see: https://www.jpiamr.eu/consultation-for-the-inclusion-of-antifungals-in-the-jpiamr-sria/ Deadline: 16-12-2020.
In June 2020 JPIAMR organised organising a series of webinars to highlight and clarify the importance of antimicrobial resistance (AMR) research in the context of the current Covid-19 pandemic and future viral pandemics. In the webinars world-leading researchers and clinicians discuss the prevalence of bacterial co-infections, best practise and appropriate use of antibiotics, and opportunities and challenges for AMR research in theCOVID-19 pandemic.
See here an overview on the open/upcoming and closed calls within JPIAMR in which ZonMw participates.
On the 19th and 20th of June the 2019 International Ministerial AMR Conference took place in Noordwijk, the Netherlands. Following up on the 2014 conference, the 2019 edition will reflect on the progress of the global implementation of the Global Implementation Plan, the work of the Tripartite (WHO, FAO, OIE) to support its implementation, and the requirements needed to accelerate multi-sectoral collaboration in the upcoming years.
JPIAMR, of which ZonMw is member, took part in one of the breakout sessions on AMR partnerships and was present at the information market. In the breakout session, the global R&D AMR Hub, GARDP and panellists from WHO, JPIAMR and governments engaged in a forward-looking discussion to identify critical challenges and what actions are needed from various actors (governments, industry, academia, UN and civil society) in order to accelerate multi-sectoral collaboration to strengthen knowledge and evidence base.
As ZonMw endorses, Bruno Bruins (Minister of Health, Welfare, and Sport) recently confirmed that we as the Netherlands should keep playing an active role in the international collaboration to tackle to the global AMR problem.
This list is non-exhaustive.
The roadmap and accompanying papers published by the PRAISE network will provide the guidance necessary for large-scale implementation of reliable automated surveillance of healthcare-associated infections (HAI). ZonMw was funder of the project.
More information & link to papers
The intent of the call is to support networks to design and implement ways to support AMR research considering at least one of the six strategic areas of the JPIAMR SRIA: Therapeutics, Diagnostics, Surveillance, Transmission, Environment and Interventions.More information >>
Covering the entire spectrum of AMR research, from science to policy and through a One Health approach, is what ZonMw strives for
View the JPIAMR AMR R&D investment dashboard. An interactive tool that shows the investments by the JPIAMR members.View the dashboard
Securing the future from drug-resistance infections - Report to the secretary-general of the United Nations.Read the report
The updated SRIA (2019) presents an overview of recent developments and future needs for AMR research.View the SRIA
The SRIA provides a framework for the JPIAMR Roadmap of Actions 2019-2024. The roadmap will guide future joint transnational actions of the JPIAMR as well as to serve as an information resource for other strategic initiatives to support coordination and synergistic actions.More information and a link to the roadmap